Pharmacogenomics-based individualization of drug therapy

被引：0
|
作者：
Mushiroda, Taisei [1 ]
机构：
[1] RIKEN Ctr Integrat Med Sci, Wako, Saitama, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2016年 / 130卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
1-AS-01-3
引用
收藏
页码：S14 / S14
页数：1
相关论文
共 50 条
  • [1] Survey of physicians' views on the clinical implementation of pharmacogenomics-based personalized therapy
    Kim, Woo-Young
    Kim, Ho-Sook
    Oh, Minkyung
    Shin, Jae-Gook
    TRANSLATIONAL AND CLINICAL PHARMACOLOGY, 2020, 28 (01) : 34 - 42
  • [2] Pharmacogenomics: Germline markers for individualization of therapy
    Relling, M. V.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2007, 22 (01): : 51 - 51
  • [3] The regulation of pharmacogenomics-based drugs and policy making
    Issa, AM
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (13) : 1455 - 1460
  • [4] Availability of pharmacogenomics-based prescribing information in drug package inserts for currently approved drugs
    I Zineh
    T Gerhard
    C L Aquilante
    A L Beitelshees
    B N Beasley
    A G Hartzema
    The Pharmacogenomics Journal, 2004, 4 : 354 - 358
  • [5] Pharmacogenomics-Based Drug Response Prediction Model for Acute Myeloid Leukemia with Normal Karyotype
    Kim, Dong Hwan
    Han, Boram
    Lee, Kyusang
    Ahn, TaeJin
    Son, Dae-soon
    Sohn, Insuk
    Jung, Sin-Ho
    Park, Kyunghee
    Jang, Jun Ho
    Kim, Kihyun
    Kim, Hyeoung Joon
    Sohn, Sang Kyun
    Moon, Joon Ho
    Kim, Jhingook
    Huh, Nam
    Jung, Chul Won
    BLOOD, 2010, 116 (21) : 1112 - 1112
  • [6] Availability of pharmacogenomics-based prescribing information in drug package inserts for currently approved drugs
    Zineh, I
    Gerhard, T
    Aquilante, CL
    Beitelshees, AL
    Beasley, BN
    Hartzema, AG
    PHARMACOGENOMICS JOURNAL, 2004, 4 (06): : 354 - 358
  • [7] How Close Are We to the Pharmacogenomics-based Personalized Pharmacotherapy?
    Shin, Jae Gook
    DRUG METABOLISM REVIEWS, 2009, 41 : 20 - 21
  • [8] Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing
    O'Donnell, P. H.
    Wadhwa, N.
    Danahey, K.
    Borden, B. A.
    Lee, S. M.
    Hall, J. P.
    Klammer, C.
    Hussain, S.
    Siegler, M.
    Sorrentino, M. J.
    Davis, A. M.
    Sacro, Y. A.
    Nanda, R.
    Polonsky, T. S.
    Koyner, J. L.
    Burnet, D. L.
    Lipstreuer, K.
    Rubin, D. T.
    Mulcahy, C.
    Strek, M. E.
    Harper, W.
    Cifu, A. S.
    Polite, B.
    Patrick-Miller, L.
    Yeo, K-T J.
    Leung, E. K. Y.
    Volchenboum, S. L.
    Altman, R. B.
    Olopade, O. I.
    Stadler, W. M.
    Meltzer, D. O.
    Ratain, M. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (05) : 859 - 869
  • [9] Individualization of Anticancer Therapeutics Based on Pharmacogenomics
    Mushiroda, T.
    PUBLIC HEALTH GENOMICS, 2015, 18 : 4 - 5
  • [10] Advancing Pharmacogenomics-Based Care Through Interprofessional Education
    Lee, Yee Ming
    Berenbrok, Lucas A.
    Galvez-Peralta, Marina
    Iwuchukwu, Otito
    Kisor, David F.
    Petry, Natasha J.
    Gammal, Roseann S.
    AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION, 2023, 87 (05)
12345